I recently attended the Artificial Intelligence in Oncology conference at Case Comprehensive Cancer Center. Vinay Varadan, Ph.D led a panel discussion on the use of AI in pathology and genomics. Some of the discussions detailed a operating system for precision medicine, Tempus, which can aid oncologists by using genomic tests to analyze DNA, RNA, and proteomic data to understand a patient’s tumor at the molecular level and then identify treatment options tailored to each and every patient. Also discussed was the use of CT scans and AI to predict responder vs. non-responder to cancer therapies. Predictive modeling will inherently help oncologists make better-informed decisions regarding patient care.